Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05715814 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis

Study acronym: CANARY
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Dec 1, 2025 to May 1, 2027 Completion date: Dec 1, 2025 to Dec 1, 2027v6 Show 1 more changeShow less
    • Completion date: Dec 1, 2025 to Dec 1, 2027
  2. Trial status: Not Yet Recruiting to Recruiting Primary and study completion dates: Jun 1, 2025 to Dec 1, 2025 · Start date changed from estimate of Jun 1, 2024 to Sep 1, 2024 · Site details revisedv5 Show 3 more changesShow less
    • Primary and study completion dates: Jun 1, 2025 to Dec 1, 2025
    • Start date changed from estimate of Jun 1, 2024 to Sep 1, 2024
    • Site details revised
  3. Start date: Feb 1, 2024 to Jun 1, 2024 Primary and study completion dates: Apr 1, 2025 to Jun 1, 2025v4 Show 1 more changeShow less
    • Primary and study completion dates: Apr 1, 2025 to Jun 1, 2025
  4. Start date: Jun 1, 2023 to Feb 1, 2024v3
  5. Start date: Apr 1, 2023 to Jun 1, 2023v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary aim of this study is to determine the safety and mechanisms of SGLT2 inhibition in individuals on peritoneal dialysis (PD) with residual kidney function (RKF).
Trial Details
NCT Number NCT05715814
Lead Sponsor University Health Network, Toronto
Conditions Peritoneal Dialysis Complication, End Stage Kidney Disease, Sodium-glucose Co-transporter-2 Inhibitors, Kidney Dysfunction, Residual Kidney Function
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov